2021
DOI: 10.1016/j.jsps.2021.06.005
|View full text |Cite
|
Sign up to set email alerts
|

Demographics, comorbidities, and outcomes among young and middle-aged COVID-19 patients in Saudi Arabia

Abstract: The impact of different sociodemographic and clinical characteristics on the COVID-19-related morbidity and mortality rates have been studied extensively around the world; however, there is a dearth of data on the impact of different clinical and sociodemographic variables on the COVID-19-related outcomes in Saudi Arabia. This study aimed to identify those at high risk of worse clinical outcomes, such as hospitalization and longer length of stay (LOS) among young and middle-aged adults (18 to 55 years). In thi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

3
12
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 16 publications
(16 citation statements)
references
References 49 publications
3
12
1
Order By: Relevance
“…In addition, non-hospitalized patients had a lower diet score but recovered quicker than hospitalized patients. The faster recovery seen here is primarily attributed to the differences between the groups in age, BMI, and comorbidities (higher in the hospitalized patients' group compared to non-hospitalized participants), as previous studies indicated [64,65].…”
Section: Discussionsupporting
confidence: 51%
“…In addition, non-hospitalized patients had a lower diet score but recovered quicker than hospitalized patients. The faster recovery seen here is primarily attributed to the differences between the groups in age, BMI, and comorbidities (higher in the hospitalized patients' group compared to non-hospitalized participants), as previous studies indicated [64,65].…”
Section: Discussionsupporting
confidence: 51%
“…The study findings are consistent with other published studies (29,30). However, few data were available on the frequency of combinations of comorbidities and symptoms (31,32) (25,29,32). Furthermore, our findings suggested that patients with comorbidities are more likely to have poorer well-being.…”
Section: Discussionsupporting
confidence: 92%
“…Despite an observed higher frequency of hyperlipidemia in hospitalized participants, we did not evaluate its association with hospitalization given the condition was reported in a free text field, reported less frequently during interviews, and many non-hospitalized patients had limited or no medical records available for review. However, in the few studies that systematically collected hyperlipidemia through chart review, patients with hyperlipidemia were less or similarly likely to be hospitalized with COVID-19 [ 6 , 56 ].…”
Section: Discussionmentioning
confidence: 99%
“…We did not differentiate between type 1 and type 2 DM in our analysis, so we are unable to determine if the relationship between DM and COVID-19 hospitalization varies by type. Additionally, we had a lower number of patients with DM, which might have reduced our power to detect an association in multivariable analysis, as was reported in at least one other study [ 35 ] compared to studies where DM was reported to occur at a higher frequency and was found to be a risk factor for hospitalization [ 7 , 27 , 29 , 30 , 34 , 48 , 55 , 56 ]. Compared to other U.S. states, Colorado’s population is relatively healthy having the lowest proportion of adults with obesity and the fourth lowest percentage of residents with at least one of six underlying medical conditions found to be associated with an increased COVID-19 case fatality ratio in China [ 62 , 63 ].…”
Section: Discussionmentioning
confidence: 99%